Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
Clinical trial NCT04026178 · COMPLETED
Trial details
- NCT number
- NCT04026178
- Sponsor
- Aegerion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2024-10-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.